Daniel Calarese

Company: Sutro Biopharma

Job title: Senior Director, Innovation & Strategy

Seminars:

Panel Discussion: Curating a Target Selection Strategy With Adequate Risk Management to Maintain Investor Buy-In & Strategic Differentiation 9:30 am

Strategizing how to penetrate the dense ADC field whilst taking adequate risks in relation to target selection or ADC design Understanding the degree of risk deemed acceptable by prospective investors to decide the target of choice Considering scenarios appropriate to advance a novel ADC with a novel task, in a high risk approachRead more

day: Conference Day Two

Diagnosing the Risk of ADC Resistance Over Time, Focusing the Evolution of the Target in Response to Specific Payloads 12:15 pm

Exploring the possibility of ADC target sub-clones expressing at the target cell in a response to specific ADC therapeutics Diving into whether specific ADC designs lend themselves to target resistance which should be considered when deciding dosing schedules Confirming whether resistance risk is a property which can be quantified in the target selection processRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.